DXCM : DexCom stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-27 |
|---|---|---|---|---|
| 2026 | $56.86 | $48.71 | $60.21 | -19.07% |
| 2027 | $87.35 | $59.82 | $137.93 | 24.32% |
| 2028 | $176.75 | $149.09 | $189.04 | 151.56% |
| 2029 | $125.27 | $100.18 | $160.9 | 78.29% |
| 2030 | $170.36 | $140.14 | $245.18 | 142.46% |
| 2031 | $279.4 | $257.34 | $288.76 | 297.67% |
| 2032 | $274.13 | $260.04 | $279.91 | 290.16% |
| 2033 | $237.58 | $226.54 | $255.71 | 238.15% |
| 2034 | $206.41 | $159.62 | $225.51 | 193.79% |
| 2035 | $147.7 | $143.14 | $154.95 | 110.22% |
| 2036 | $140.54 | $139.18 | $142.2 | 100.02% |
The 17 Wall Street analysts offering DexCom stock forecast in the last 6 months have average price target of
$81.88 with a high forecast of $100.0 and a low forecast of $64.0.
The average DexCom stock forecast represents a 16.54%
increase from the last price of $70.2600021362305.
For DexCom stock forecast for 2026, 7 predictions are offered for each month of 2026 with average DexCom stock
forecast of $56.86, a high forecast of $60.21, and a low forecast of $48.71.
The average DexCom stock forecast 2026 represents a -19.07%
decrease from the last price of $70.2600021362305.
For DexCom stock forecast for 2027, 12 predictions are offered for each month of 2027 with average DexCom stock
forecast of $87.35, a high forecast of $137.93, and a low forecast of $59.82.
The average DexCom stock forecast 2027 represents a 24.32%
increase from the last price of $70.2600021362305.
For DexCom stock forecast for 2029, 12 predictions are offered for each month of 2029 with average DexCom stock
forecast of $125.27, a high forecast of $160.9, and a low forecast of $100.18.
The average DexCom stock forecast 2029 represents a 78.29%
increase from the last price of $70.2600021362305.
For DexCom stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average DexCom stock
forecast of $279.4, a high forecast of $288.76, and a low forecast of $257.34.
The average DexCom stock forecast 2031 represents a 297.67%
increase from the last price of $70.2600021362305.
For DexCom stock forecast 2032, 12 predictions are offered for each month of 2032 with average DexCom stock
forecast of $274.13, a high forecast of $279.91, and a low forecast of $260.04.
The average DexCom stock forecast 2032 represents a 290.16%
increase from the last price of $70.2600021362305.
For DexCom stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average DexCom stock
forecast of $140.54, a high forecast of $142.2, and a low forecast of $139.18.
The average DexCom stock forecast 2036 represents a 100.02%
increase from the last price of $70.2600021362305.
Please, see more forecasts below.
DXCM : DexCom stock forecast by Wall Street Analysts
The average DexCom stock forecast from last 6 month is $81.88, and this show a -3.07% decrease in average from the prior price target of the each prediction. Also, this average forecast of $81.88 represents a -6.39% decrease from the past average forecast of $87.47, 6 months ago from 32 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-28 | Citigroup | $79.00 | $84.0000 | Buy |
| 2026-05-18 | Barclays | $67.0000 | $64.0000 | Underweight |
| 2026-05-18 | B of A Securities | $100.0000 | $80.0000 | Buy |
| 2026-05-18 | Canaccord Genuity | $100.00 | $82.0000 | Buy |
| 2026-05-04 | Citigroup | $84.00 | $79.0000 | Buy |
| 2026-05-01 | TD Cowen | $84.0000 | $75.0000 | Buy |
| 2026-05-01 | Canaccord Genuity | $95.00 | $100.0000 | Buy |
| 2026-05-01 | Barclays | $72.00 | $67.0000 | Underweight |
| 2026-03-11 | Citigroup | $77.00 | $84.0000 | Buy |
| 2026-03-09 | BTIG | $85.00 | $85.0000 | Buy |
| 2026-02-25 | BTIG | $85.0000 | $85.0000 | Buy |
| 2026-02-17 | Truist Securities | $82.00 | $80.0000 | Buy |
| 2026-02-13 | Barclays | $71.00 | $72.0000 | Underweight |
| 2026-02-13 | Canaccord Genuity | $99.0000 | $95 | Buy |
| 2026-02-13 | Wells Fargo | $93.00 | $85.0000 | Overweight |
| 2026-02-13 | Mizuho | $78.00 | $90.0000 | Outperform |
| 2026-02-13 | BTIG | $85.0000 | $85.0000 | Buy |
| 2026-01-12 | Barclays | $80.0000 | $71.0000 | Underweight |
| 2026-01-09 | Bernstein | $84.0000 | $86.0000 | Outperform |
| 2025-12-17 | Mizuho | $75.0000 | $78.0000 | Outperform |
| 2025-12-11 | Citigroup | $75.0000 | $77.0000 | Buy |
| 2025-12-02 | Morgan Stanley | $63.00 | $75.0000 | Overweight |
| 2025-11-25 | Evercore ISI Group | $68.0000 | In-Line | |
| 2025-11-10 | Morgan Stanley | $89.00 | $63.0000 | Equal-Weight |
| 2025-11-07 | Argus Research | $100.00 | $90.0000 | Buy |
| 2025-11-03 | Barclays | $98.00 | $80.0000 | Equal-Weight |
| 2025-11-03 | UBS | $106.00 | $95.0000 | Buy |
| 2025-11-03 | Truist Securities | $94.00 | $82 | Buy |
| 2025-10-31 | RBC Capital | $100.0000 | $85.0000 | Outperform |
| 2025-10-31 | Piper Sandler | $100.00 | $75 | Overweight |
| 2025-10-31 | TD Cowen | $100.0000 | $84.0000 | Buy |
| 2025-10-31 | JP Morgan | $90.0000 | $75.0000 | Neutral |
| 2025-10-31 | Citigroup | $85.00 | $75.0000 | Buy |
| 2025-10-31 | Canaccord Genuity | $106.0000 | $99.0000 | Buy |
| 2025-10-31 | Wells Fargo | $98.0000 | $93.0000 | Overweight |
| 2025-10-31 | BTIG | $109.0000 | $85.0000 | Buy |
| 2025-10-21 | Stifel | $85.0000 | Buy | |
| 2025-10-15 | Truist Securities | $102.00 | $94.0000 | Buy |
| 2025-10-07 | Citigroup | $105.0000 | $85.0000 | Buy |
| 2025-10-01 | Goldman Sachs | $104.0000 | $89.0000 | Buy |
| 2025-09-29 | Canaccord Genuity | $106.00 | $106.00 | Buy |
| 2025-09-26 | Baird | $112.0000 | $90.0000 | Outperform |
| 2025-08-21 | Argus Research | $100.0000 | Buy | |
| 2025-08-01 | Canaccord Genuity | $106.0000 | $106 | Buy |
| 2025-07-31 | Oppenheimer | $95.0000 | $102 | Outperform |
| 2025-07-31 | UBS | $105.0000 | $106.0000 | Buy |
| 2025-07-31 | Piper Sandler | $90.00 | $100 | Overweight |
| 2025-07-31 | Raymond James | $99.00 | $102 | Strong Buy |
| 2025-07-30 | Barclays | $93.00 | $98.0000 | Equal-Weight |
DexCom stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-28 | $68.30 | -2.79% |
| 2026-05-29 | $67.14 | -1.70% |
| 2026-06-01 | $67.97 | 1.23% |
| 2026-06-02 | $67.67 | -0.44% |
| 2026-06-03 | $67.72 | 0.06% |
DXCM : Long term DexCom stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $59.09 , for 2027 May. is $73.37 , for 2030 May. is $143.08 , for 2031 May. is $282.78 , for 2035 May. is $148.18 , and for 2036 May. is $139.18.
DXCM : DexCom stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $59.09 | -15.90% |
| 2026 Jul. | $48.71 | -17.56% |
| 2026 Aug. | $52.87 | 8.52% |
| 2026 Sep. | $57.41 | 8.59% |
| 2026 Oct. | $59.70 | 3.98% |
| 2026 Nov. | $60.21 | 0.86% |
| 2026 Dec. | $60.04 | -0.28% |
DXCM : DexCom stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $59.82 | -0.37% |
| 2027 Feb. | $60.96 | 1.91% |
| 2027 Mar. | $63.62 | 4.36% |
| 2027 Apr. | $67.84 | 6.63% |
| 2027 May. | $73.37 | 8.14% |
| 2027 Jun. | $77.93 | 6.21% |
| 2027 Jul. | $82.35 | 5.67% |
| 2027 Aug. | $88.60 | 7.60% |
| 2027 Sep. | $97.94 | 10.54% |
| 2027 Oct. | $111.75 | 14.10% |
| 2027 Nov. | $126.02 | 12.76% |
| 2027 Dec. | $137.93 | 9.46% |
DXCM : DexCom stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $149.09 | 8.09% |
| 2028 Feb. | $159.60 | 7.05% |
| 2028 Mar. | $168.73 | 5.72% |
| 2028 Apr. | $176.07 | 4.35% |
| 2028 May. | $181.57 | 3.12% |
| 2028 Jun. | $185.13 | 1.96% |
| 2028 Jul. | $187.59 | 1.33% |
| 2028 Aug. | $189.04 | 0.77% |
| 2028 Sep. | $188.63 | -0.21% |
| 2028 Oct. | $185.47 | -1.68% |
| 2028 Nov. | $179.28 | -3.33% |
| 2028 Dec. | $170.80 | -4.73% |
DXCM : DexCom stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $160.90 | -5.79% |
| 2029 Feb. | $149.32 | -7.20% |
| 2029 Mar. | $136.38 | -8.67% |
| 2029 Apr. | $123.76 | -9.25% |
| 2029 May. | $113.52 | -8.28% |
| 2029 Jun. | $106.50 | -6.18% |
| 2029 Jul. | $102.20 | -4.04% |
| 2029 Aug. | $100.18 | -1.97% |
| 2029 Sep. | $102.01 | 1.83% |
| 2029 Oct. | $127.48 | 24.97% |
| 2029 Nov. | $138.79 | 8.87% |
| 2029 Dec. | $142.15 | 2.42% |
DXCM : DexCom stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $141.36 | -0.56% |
| 2030 Feb. | $140.51 | -0.60% |
| 2030 Mar. | $140.14 | -0.26% |
| 2030 Apr. | $140.87 | 0.53% |
| 2030 May. | $143.08 | 1.57% |
| 2030 Jun. | $147.40 | 3.02% |
| 2030 Jul. | $154.93 | 5.11% |
| 2030 Aug. | $167.23 | 7.94% |
| 2030 Sep. | $185.75 | 11.08% |
| 2030 Oct. | $208.73 | 12.37% |
| 2030 Nov. | $229.08 | 9.75% |
| 2030 Dec. | $245.18 | 7.03% |
DXCM : DexCom stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $257.34 | 4.96% |
| 2031 Feb. | $266.45 | 3.54% |
| 2031 Mar. | $273.38 | 2.60% |
| 2031 Apr. | $278.73 | 1.96% |
| 2031 May. | $282.78 | 1.45% |
| 2031 Jun. | $285.70 | 1.03% |
| 2031 Jul. | $287.75 | 0.72% |
| 2031 Aug. | $288.76 | 0.35% |
| 2031 Sep. | $287.55 | -0.42% |
| 2031 Oct. | $283.88 | -1.28% |
| 2031 Nov. | $280.86 | -1.06% |
| 2031 Dec. | $279.63 | -0.44% |
DXCM : DexCom stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $279.08 | -0.20% |
| 2032 Feb. | $278.65 | -0.15% |
| 2032 Mar. | $278.17 | -0.17% |
| 2032 Apr. | $277.88 | -0.10% |
| 2032 May. | $278.79 | 0.33% |
| 2032 Jun. | $279.91 | 0.40% |
| 2032 Jul. | $278.34 | -0.56% |
| 2032 Aug. | $275.17 | -1.14% |
| 2032 Sep. | $271.57 | -1.31% |
| 2032 Oct. | $267.88 | -1.36% |
| 2032 Nov. | $264.07 | -1.42% |
| 2032 Dec. | $260.04 | -1.53% |
DXCM : DexCom stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $255.71 | -1.67% |
| 2033 Feb. | $251.14 | -1.78% |
| 2033 Mar. | $246.67 | -1.78% |
| 2033 Apr. | $242.81 | -1.57% |
| 2033 May. | $239.60 | -1.32% |
| 2033 Jun. | $236.33 | -1.37% |
| 2033 Jul. | $233.61 | -1.15% |
| 2033 Aug. | $231.59 | -0.86% |
| 2033 Sep. | $230.16 | -0.62% |
| 2033 Oct. | $229.00 | -0.50% |
| 2033 Nov. | $227.80 | -0.52% |
| 2033 Dec. | $226.54 | -0.55% |
DXCM : DexCom stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $225.51 | -0.46% |
| 2034 Feb. | $224.73 | -0.34% |
| 2034 Mar. | $224.06 | -0.30% |
| 2034 Apr. | $223.90 | -0.07% |
| 2034 May. | $224.41 | 0.23% |
| 2034 Jun. | $224.07 | -0.15% |
| 2034 Jul. | $220.10 | -1.77% |
| 2034 Aug. | $209.87 | -4.65% |
| 2034 Sep. | $194.35 | -7.39% |
| 2034 Oct. | $179.00 | -7.90% |
| 2034 Nov. | $167.34 | -6.52% |
| 2034 Dec. | $159.62 | -4.61% |
DXCM : DexCom stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $154.95 | -2.93% |
| 2035 Feb. | $152.23 | -1.75% |
| 2035 Mar. | $150.50 | -1.14% |
| 2035 Apr. | $149.22 | -0.85% |
| 2035 May. | $148.18 | -0.69% |
| 2035 Jun. | $147.32 | -0.58% |
| 2035 Jul. | $146.62 | -0.48% |
| 2035 Aug. | $146.01 | -0.41% |
| 2035 Sep. | $145.43 | -0.40% |
| 2035 Oct. | $144.78 | -0.45% |
| 2035 Nov. | $144.01 | -0.53% |
| 2035 Dec. | $143.14 | -0.61% |
DXCM : DexCom stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $142.20 | -0.65% |
| 2036 Feb. | $141.26 | -0.66% |
| 2036 Mar. | $140.39 | -0.62% |
| 2036 Apr. | $139.66 | -0.52% |
| 2036 May. | $139.18 | -0.34% |
Financial Data for DexCom stock
Frequently Asked Questions about DexCom stock forecast
Is DexCom a good long term stock?
From DexCom stock forecast , DexCom (DXCM) stock cannot be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2026 Jun. is $59.0909210637101 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2027 May. is $73.3681561382885 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2030 May. is $143.083598136663 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2031 May. is $282.784822652379 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2035 May. is $148.183455842885 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2036 May. is $139.182004472161
Is DexCom stock overvalued?
DexCom (DXCM) stock is expected to go UP . Therefore, AIPickup would say that DexCom (DXCM) stock is NOT overvalued.
Will DexCom stock price go up?
Yes. The DexCom stock price forecast for 2027 May. is $73.3681561382885
Is DexCom stock a good buy now?
Since closing price on 2026-05-27 is $70.2600021362305 and forecast for 2027 May. is $73.37, DexCom stock is a good 1 year investment.
14 Days Historical Data for DexCom stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| DXCM stock price for 2026-05-07 | $60.91 | $60.36 | $60.35 | $61.55 |
| DXCM stock price for 2026-05-08 | $60.61 | $60.91 | $60.13 | $61.37 |
| DXCM stock price for 2026-05-11 | $59.33 | $60.34 | $58.43 | $60.59 |
| DXCM stock price for 2026-05-12 | $61.14 | $60.14 | $59.65 | $61.46 |
| DXCM stock price for 2026-05-13 | $58.57 | $60.45 | $58.53 | $61.36 |
| DXCM stock price for 2026-05-14 | $57.82 | $59.02 | $57.66 | $59.56 |
| DXCM stock price for 2026-05-15 | $61.63 | $59.91 | $59.46 | $63.19 |
| DXCM stock price for 2026-05-18 | $65.09 | $61.79 | $61.54 | $65.17 |
| DXCM stock price for 2026-05-19 | $66.95 | $65.28 | $64.47 | $67.75 |
| DXCM stock price for 2026-05-20 | $71.44 | $66.71 | $66.30 | $71.48 |
| DXCM stock price for 2026-05-21 | $71.90 | $71.50 | $70.18 | $72.27 |
| DXCM stock price for 2026-05-22 | $72.10 | $71.90 | $71.31 | $73.05 |
| DXCM stock price for 2026-05-26 | $72.01 | $72.02 | $70.14 | $73.10 |
| DXCM stock price for 2026-05-27 | $70.26 | $72.53 | $69.92 | $72.65 |